These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16650878)

  • 1. Endostatin influences endothelial morphology via the activated ERK1/2-kinase endothelial morphology and signal transduction.
    Schmidt A; Wenzel D; Thorey I; Sasaki T; Hescheler J; Timpl R; Addicks K; Werner S; Fleischmann BK; Bloch W
    Microvasc Res; 2006 May; 71(3):152-62. PubMed ID: 16650878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endostatin down-regulates soluble guanylate cyclase (sGC) in endothelial cells in vivo: influence of endostatin on vascular endothelial growth factor (VEGF) signaling.
    Schmidt A; Wenzel D; Thorey I; Werner S; Fleischmann BK; Bloch W
    Endothelium; 2005; 12(5-6):251-7. PubMed ID: 16410224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.
    Campbell M; Collery R; McEvoy A; Gardiner TA; Stitt AW; Brankin B
    Curr Eye Res; 2006 Dec; 31(12):1033-45. PubMed ID: 17169842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
    Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
    J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of endostatin on embryonic vasculo- and angiogenesis.
    Schmidt A; Wenzel D; Ferring I; Kazemi S; Sasaki T; Hescheler J; Timpl R; Addicks K; Fleischmann BK; Bloch W
    Dev Dyn; 2004 Jul; 230(3):468-80. PubMed ID: 15188432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing.
    Bloch W; Huggel K; Sasaki T; Grose R; Bugnon P; Addicks K; Timpl R; Werner S
    FASEB J; 2000 Dec; 14(15):2373-6. PubMed ID: 11024009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endostatin/collagen XVIII--an inhibitor of angiogenesis--is expressed in cartilage and fibrocartilage.
    Pufe T; Petersen WJ; Miosge N; Goldring MB; Mentlein R; Varoga DJ; Tillmann BN
    Matrix Biol; 2004 Aug; 23(5):267-76. PubMed ID: 15464359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
    Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
    Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways.
    Shen J; DiCorleto PE
    Circ Res; 2008 Feb; 102(4):448-56. PubMed ID: 18174464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endostatin, the proteolytic fragment of collagen XVIII, induces vasorelaxation.
    Wenzel D; Schmidt A; Reimann K; Hescheler J; Pfitzer G; Bloch W; Fleischmann BK
    Circ Res; 2006 May; 98(9):1203-11. PubMed ID: 16574906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G/MAPK pathway.
    Pyriochou A; Zhou Z; Koika V; Petrou C; Cordopatis P; Sessa WC; Papapetropoulos A
    J Cell Physiol; 2007 Apr; 211(1):197-204. PubMed ID: 17226792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble multimer of recombinant endostatin expressed in E. coli has anti-angiogenesis activity.
    Wei DM; Gao Y; Cao XR; Zhu NC; Liang JF; Xie WP; Zhen MY; Zhu MS
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1398-404. PubMed ID: 16723120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-related growth factor enhances blood flow via activation of the ERK1/2-eNOS-NO pathway in a mouse hind-limb ischemia model.
    Urano T; Ito Y; Akao M; Sawa T; Miyata K; Tabata M; Morisada T; Hato T; Yano M; Kadomatsu T; Yasunaga K; Shibata R; Murohara T; Akaike T; Tanihara H; Suda T; Oike Y
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):827-34. PubMed ID: 18258819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effects of endostatin on endothelial cells are modulated by extracellular matrix.
    Delaney CE; Weagant BT; Addison CL
    Exp Cell Res; 2006 Aug; 312(13):2476-89. PubMed ID: 16725139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endostatin signaling and regulation of endothelial cell-matrix interactions.
    Wickström SA; Alitalo K; Keski-Oja J
    Adv Cancer Res; 2005; 94():197-229. PubMed ID: 16096002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue factor pathway inhibitor (TFPI) interferes with endothelial cell migration by inhibition of both the Erk pathway and focal adhesion proteins.
    Provençal M; Michaud M; Beaulieu E; Ratel D; Rivard GE; Gingras D; Béliveau R
    Thromb Haemost; 2008 Mar; 99(3):576-85. PubMed ID: 18327407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin.
    Ramchandran R; Dhanabal M; Volk R; Waterman MJ; Segal M; Lu H; Knebelmann B; Sukhatme VP
    Biochem Biophys Res Commun; 1999 Feb; 255(3):735-9. PubMed ID: 10049780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide reduces electrical coupling in microvascular endothelial cells by targeting connexin40 in a tyrosine-, ERK1/2-, PKA-, and PKC-dependent manner.
    Bolon ML; Kidder GM; Simon AM; Tyml K
    J Cell Physiol; 2007 Apr; 211(1):159-66. PubMed ID: 17149706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.